Categories AlphaGraphs, Cannabis, Earnings
Tilray Q2 loss widens despite revenue growth; results miss
Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite a marked increase in revenues.
Revenues of the Canada-based company increased by 10% to $50.4 million in the June quarter but fell short of the forecast. The growth reflects strong performance by the cannabis adult-use and international-medical channels.
Meanwhile, net loss widened to $81.69 million or $0.66 per share in the second quarter from $36.3 million or $0.37 per share in the comparable period of 2019. Analysts were looking for a narrower loss for the latest quarter.
Tilray’s stock has fallen 74% in the past twelve months. The stock closed Monday’s regular session higher but dropped sharply during the extended session soon after the announcement.
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
